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Abstract
1. Using the two electrode voltage clamp configuration, a high voltage activated whole-cell Ca2+ channel current (IBa) was record-
ed from a cluster of neurosecretory ‘Light Yellow’ Cells (LYC) in the right parietal ganglion of the pond snail Lymnaea stagnalis.
2. Recordings of IBa from LYCs show a reversible concentration-dependent depression of current amplitude in the presence of the 
volatile anaesthetics halothane, isoflurane and sevoflurane, or the non-volatile anaesthetic pentobarbitone at clinical concen-
trations.
3. In the presence of the anaesthetics investigated, IBa measured at the end of the depolarizing test pulse showed proportionally 
greater depression than that at measured peak amplitude, as well as significant decrease in the rate of activation or increase 
in inactivation or both. 
4. Within the range of concentrations used, the concentration-response plots for all the anaesthetics investigated correlate 
strongly to straight line functions, with linear regression R2 values > 0.99 in all instances.
5. For volatile anaesthetics, the dose-response regression slopes for IBa increase in magnitude, in order of gradient: sevoflurane, 
isoflurane and halothane, a sequence which reflects their order of clinical potency in terms of MAC value.
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Introduction
General anaesthetics form a chemically diverse group of agents which have in common the property of inducing narcosis and analgesia 
to varying degrees. They tend to depress neuronal excitability and synaptic transmission, though detailed responses vary for the particu-
lar drug and are often cell specific. Work with both vertebrate and invertebrate neuronal preparations has shown both [Ca2+]i (intracel-
lular calcium concentration) and Ca2+ influx to be dramatically affected by a number of anaesthetics. Increases in [Ca2+]i in the presence of 
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volatile anaesthetics has been shown in CA1 hippocampal cells in rats [1] and cultured molluscan neurons in the absence of extracellular 
Ca2+[2,3], implying an anaesthetic triggered release of Ca2+ from intracellular stores. Voltage-gated calcium channels within the cell mem-
branes also appear to be important targets for these agents and calcium influx has been shown to decrease in a dose-dependent manner 
in their presence [4]. T-type calcium currents (see below) have also been shown to be differentially sensitive to volatile anaesthetics at 
clinical concentrations in various cell types [5]. These are interesting findings but the dual action of Ca2+ adds complexity to understanding 
global effects on cell activity. Ca2+ is also a major second messenger and plays a central role in the control of a variety of cell processes, so 
that alterations of calcium influx and [Ca2+]i have the potential to modify numerous, interrelated neuronal functions. Transient increases 
in [Ca2+]i may be initiated by release from intracellular storage sites associated with the endoplasmic reticulum [6] and/or an increase in 
Ca2+ permeability of the plasma membrane associated with neural activity or the actions of neurotransmitters [7] and may operate by a 
calcium-induced calcium release mechanism [8,9].
In vertebrate tissues, calcium channels have been classified by their electrophysiological and biochemical properties. Nowycky., et al. 
[10] identified three types of Ca2+ channel in whole-cell currents recorded from chick dorsal root ganglion cells, called L-type, T-type and 
N-type. They have become the prototypes that form the basis of a widely accepted system of calcium channel classification [11-13]. The 
transient T-type current is activated by small depolarisations, termed Low-Voltage-Activated (LVA), whilst sustained L-type currents are 
activated by large depolarisations - High-Voltage-Activated (HVA) - and blocked by organic calcium channel antagonists. N-type currents 
are also included in the HVA category but can be transient or sustained. An increasing number of calcium channels from both vertebrate 
[14] and non-vertebrate systems [15] have proven difficult to identify within this scheme. Molluscan neurons in particular can display 
HVA Ca2+ currents with conflicting pharmacological and electrophysiological profiles [16], but L-type currents have clearly been identified 
as the sole HVA current in isolated, cultured pedal I cluster neurons of Lymnaea stagnalis [17].
The molluscan CNS (central nervous system) has several specific advantages for the neurobiologist exemplified in Lymnaea [18,19]; 
nerve cells are accessible, relatively simply organised, easily identified and in many cases large enough for two electrode work. Moreover, 
volatile anaesthetics produce many changes in behavior and neuronal activity in Lymnaea that equate well to those found in mammals 
[20-22] and facilitate its use as a single “model” system in studies on anaesthetic mechanisms at behavioral and cellular levels [23-25]. 
The HVA calcium currents recorded from the cultured pedal I cluster neurons of Lymnaea [4] using single electrode voltage clamp 
showed a reversible, dose-dependent suppression of Ba2+ mediated current by halothane at concentrations ranging between 0.5 to 4.0 
percent. Here we report on data using the two-electrode voltage clamp technique to investigate calcium channel currents recorded from 
the Light Yellow Cell (LYC) group of neurosecretory neurons in the right parietal ganglion of Lymnaea in the intact brain, which play a 
general role in body fluid regulation [26]. They lie on the ventral lobe of the right parietal ganglion and can be observed from either the 
dorsal or ventral surface of the ganglion. LYCs have large somata and fire spontaneous bursts of spikes [27]. Their action potentials have 
a prominent shoulder or pseudoplateau phase, believed to be largely Ca2+ driven [27,28]. 
Studies of the effects of general anaesthetics on voltage gated Ca2+ channels have often involved the use of a variety of preparations and 
cell type, frequently at concentrations outside the clinical range. 
Purpose of the Study
The purpose of this study was, therefore, to determine the action of a number of general anaesthetics, at clinical concentrations, on 
calcium currents recorded from the same identified cell group in a single model system. In this way the dose-response profile and relative 
potency of each agent can be directly compared. Here, we characterize the electrophysiology and pharmacology of the LYC Ca2+ currents, 
and the effects upon them of clinical concentrations of the volatile anaesthetics halothane, isoflurane and sevoflurane and the systemic 
anaesthetic sodium pentobarbital, which is now mostly used in veterinary anesthesia [29].
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Methods
Snail brains were prepared according to the methods of Benjamin and Winlow [30] in a HEPES buffered snail saline (see below) at 
room temperature, approximately 20°C. Briefly, intact central ganglia were pinned out in the perfusion chamber, ventral surface upper-
most, and the sheath of connective tissue removed from the right parietal ganglion with fine ground forceps. The inner cell integument 
was softened with several drops of protease solution (Pronase from Streptomyces griseus, Boehringer Mannheim Biochemica, in a solution 
of 4 mg/ml of snail saline) applied directly to the ganglia and washed off thoroughly with saline after about 3 minutes. The preparation 
was then perfused continuously at 3.5 ml per minute with aerated saline. After 10 - 15 minutes the perfusing medium was switched to 
the recording solution, also at room temperature, after which a cell within the LYC cluster was selected for microelectrode penetration.
Solutions: Preliminary dissection and perfusion prior to recording was carried out in a snail saline (Benjamin and Winlow, 1981) con-
taining (mmol l-1): Na+ 59.4, K+ 2.0, Mg2+ 2.0, Ca2+ 4.0, Cl- 38.0, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 50.0 and 
glucose 0.3. The pH was corrected to 7.8 with 2M NaOH. 
All current measurements were made from cells in the intact brain, bathed in recording solution which contained (mmol l-1): Na+ 6.5, 
Cs+ 2.0, Mg2+ 1.5, Ba2+ 10, Cl- 23, Br- 30, tetraethylammonium (TEA) 30, 4-aminopyridine 10, HEPES 10, glucose 5 and pyruvate 10. The 
whole cell currents measured were Ba2+ currents rather than Ca2+ currents per se. Ba2+ was used as the charge carrying ion since no cur-
rents were detectable when Ba2+ was replaced by Ca2+. Possible explanations for this are first, that the calcium channels in these cells are 
much more permeant to Ba2+ than to Ca2+, thereby increasing the signal to noise ratio to a resolvable level and, second, Ca2+ entering the 
cell might produce Ca2+-dependent inactivation of the channels being studied. Ba2+ also has the advantage that it blocks contaminating K+ 
currents, which were further blocked by the presence of TEA+ and Cs+ in the recording solution. [Na+]out was kept low to exclude voltage-
dependent Na+ currents. The addition of pyruvate was found to increase the recording time of cells considerably. Organic Ca2+-channel 
blockers, verapamil (Sigma) and nifedipine (Sigma), were dissolved initially in ethanol to give stock solutions of 1 mg ml-1 before being 
diluted in the recording solution to the required concentration.
The pipette filling solution, modified from Orchard., et al. [31] contained (mmol l-1): KCl 2500, calcium buffer ethylene glycol-bis (-ami-
no-ethyl ether) N,N’-tetra-acetic acid (EGTA) and K-ATP 10. 
Administration of anaesthetics: Volatile anaesthetics were vaporized into air using Ohmeda vaporizers set to the desired percentage 
mixture. The anaesthetic-air mixture was bubbled at 1 litre per minute into a small volume (about 150 ml) of recording solution in a 250 
ml flask and vented though a closed extraction system. Percentage vapour concentration was routinely calibrated using a Normac anaes-
thetic agent monitor. Equilibration time was taken as 15 - 20 minutes [22] after which a stopper containing an underwater seal air inlet 
was inserted and the solution used immediately via a closed delivery system. Millimolar concentrations of isoflurane at 1, 2 and 4% were 
determined by gas-liquid chromatography as (mean ± SD for n = 3): 0.44 ± 0.05, 0.76 ± 0.18 and 1.89 ± 0.37 respectively (in an ideally 
equilibrated solution a 1% vol/vol concentration of gas represents 0.42 mM). These values approximate those for equilibrated halothane 
solutions [32] and are very close to the normal clinical concentration of halothane in arterial blood [33]. 
The clinical use of pentobarbitone in humans is nowadays rare, although it may be used in veterinary anesthesia [29]. Therefore, 
most uptake studies are on barbiturates used in contemporary anaesthesia, thiopentone sodium in particular. Thiopentone sodium has 
the same clinical potency as pentobarbitone [34] but possesses contrasting and more desirable pharmacokinetic properties [35]. The 
concentration range of pentobarbitone used in this investigation was 200 to 800 µM, which equates to approximately 50 to 200 µg per 
ml of recording solution. The median dose of thiopentone required to induce anaesthesia is about 3.5 mg/kg body weight, equivalent to 
approximately 100 µg/ml plasma concentration [36].
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Recording from cells: Micropipettes (resistance 8 - 10 MΩ) were pulled on a one stage vertical puller using filamented borosilicate 
glass (Clarke Electromedical Instruments). An Axoclamp 2A amplifier was used to clamp cells and acquire data via proprietary software 
(PClamp 6.0) running on a 486 DX 33MHz IBM clone PC through an Axoclamp Digidata 1200 digital-analogue interface. Data were sam-
pled at 5 kHz, with automatic leak subtraction, estimated electronically before each test pulse as the sum of currents developed during a 
series of four inverted pulse steps at ¼ amplitude of the test pulse itself. A Gaussian filter with 500 Hz cut-off was applied to the raw data 
after acquisition to attenuate noise. 
Optimum results were achieved when the preparation was allowed to equilibrate in recording solution 4 - 6 minutes before inserting 
microelectrodes into the selected cell. Passive electrical parameters of the cell membrane were measured by manually injecting current. 
Mean values for initial τ and input resistance were, respectively (mean ± S.E. for n = 25): 78.3 ± 5.6 ms, 20.7 ± 1.7 MΩ. Useable cells had 
an initial input resistance > 10 MΩ and τ of approximately 50 ms, although these values could increase by up to a factor of 3 once the cell 
was clamped to the holding potential of -70 mV. At the holding potential, calcium channel current was monitored in response to single 
depolarizing pulses to 0 mV, and would gradually increase in magnitude over several minutes, reaching a stable value of between 40 to 
150 nA, depending on cell size. From the same holding potential, current-voltage (I-V) curves were constructed by applying depolarizing 
voltage pulses (duration 70 or 150 ms) over a range of test potentials in increments of 7 or 10 mV. 
For experiments involving the application of drugs I-V pulse protocols were first performed in the control situation at a holding poten-
tial of -70 mV. During perfusion with the control solution and subsequently the test solution, a series of unitary depolarisations to 0 mV 
were applied. When the calcium channel current re-stabilised another I-V curve was obtained as above. Between applications of the same 
drug at different concentrations, the preparation was washed with control solution until the calcium current amplitude closely approxi-
mated the control value.
Statistical analysis 
Data are expressed as mean ± standard error as appropriate.
Results
The properties of whole cell calcium channel currents recorded from LYCs
Two electrode voltage clamp recordings from LYCs in Lymnaea revealed large inward currents elicited by depolarizing the cells from 
a holding potential of -70 mV in the recording solution with Ba2+ as the charge carrier. Figure 1A shows a selection of current traces re-
corded from a large LYC. The inward current (IBa) was elicited during stepped depolarisations of 70 ms, to test potentials between -50 
and + 48 mV in 7mV steps. Currents disappeared when Ba2+ was omitted from the external solution, but increased in amplitude as [Ba2+]
out increased (not shown). IBa was neither affected by nifedipine at 50 µM nor verapamil at 20 µM but was completely abolished by Cd2+ 
at 100 µM. At small depolarisations the current is slow to activate, but the activation rate increases in step with larger depolarisations. 
Inactivation is slow, and partial, but increases slightly in rate with larger depolarisations. These observations are summarized in table 1, 
which gives the time constant for activation and the time to peak for weak and strong depolarisations, both of which are larger for test 
pulses to -30 mV than to 0 mV. 
Test Pulse 
(mV)
Time to peak  
(ms ± s.e.) [n]
Time constant (τ) for activation 
(ms ± s.e.) [n]
Time constant (τ) for inactivation 
(ms ± s.e.) [n]
−30 39.6 ± 3.40 [6] 9.18 ± 3.8 [4] 92.4 ± 8.5 [4]
0 19.90 ± 1.06 [6] 3.85 ± 0.307 [5] 44.78 ± 5.63 [4]
Table 1: Activation and inactivation parameters of IBa recorded from LYC in response to stepped depolarisations  
of 150 ms from the holding potential of −70mV.
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Figure 1: A) Whole cell Ba2+ currents recorded from a LYC neuron in Lymnaea stagnalis held at -70 mV and step depolarised for 70 ms 
to the test potentials indicated next to each current trace. (B) I-V curve of peak amplitude of currents in ‘A’. (C) I-V curves for peak (), 
sustained () and transient (   ) current measurements recorded from a different LYC, step depolarised for 150 ms at each test potential in 
10 mV increments.
In figure 1B, the amplitude measured at the peak of each trace is plotted against test potential, to show the current voltage (I-V) re-
lationship for peak current. Inward current first appears at about -45 mV and increases in amplitude with stronger depolarisations to a 
maximum (IBa(max)) at -15 mV and appears to reverse at about +50 mV. Considering the bimodal activation kinetics observed in current 
traces, the co-existence of discrete, multiple current components with different activation kinetics could not be excluded. Therefore, in 
another LYC, IBa was measured at the peak (Ipeak) and near the end of 150 ms test pulses, when current amplitude becomes sustained (Isus). 
Shown in figure 1C are I-V plots for Ipeak and Isus and the measured difference between them (Itrans), effectively the amount of current that 
inactivates during a complete step. To characterize these components further, steady state inactivation was explored by varying the hold-
ing potential prior to depolarizing the cell to approximately IBa(max). The plots of IBa(max) for Itrans and Isus against holding potential fit quite well 
to a single sigmoidal shaped curve (Figure 2) and there were no significant differences between the level of steady state inactivation of 
any of these currents at each holding potential. Both sustained and transient components begin to activate at -70 mV, are 50% inactivated 
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at a holding potential of 41 mV and are fully inactivated when the holding potential reaches -20 mV. Therefore, variation of the holding 
potential does not separate transient and sustained components of IBa.
Figure 2: Steady state inactivation curve for Isus and Itrans, recorded from 8 cells. Currents are expressed as a percentage of the  
corresponding transient and sustained currents at the holding potential of −100mV for a test potential of −15mV. Holding potentials were 
(mV) −100, −80, −60, −40, −30, and −20. No significant differences were found between transient and sustained values at each holding 
potential, using a paired t-test. A single curve was fitted to all data points by the least squares method using the Boltzmann distribution: I/
Imax = 1/[1+exp(Vh−V1/2)/k] where V1/2 = −40.88 mV, Vh is the holding potential and k = 7.08 mV.
 The effect of anaesthetics on IBa
Calcium channel currents recorded from LYCs were reversibly depressed in the presence of all the anaesthetics tested. For example, 
figure 3A shows the effect of halothane on current traces of IBa(max) recorded from a single LYC. When halothane is applied at 1, 2 and 4%, 
current amplitude is reduced for the duration of the depolarizing pulse in a dose dependent manner. Figure 3B is a time course plot of 
peak and end-pulse current elicited by unitary depolarisations to 0 mV recorded during a typical halothane experiment, showing these 
effects to be fully reversible. In all cases the current at peak amplitude was less sensitive to anaesthetic than that recorded at the end of the 
depolarizing pulse (compare dose-response plots in figure 4B). There was also a tendency for activation rates to decrease and inactiva-
tion to increase instep with increasing anaesthetic concentration. For example, at the highest concentrations used, activation rates were 
significantly decreased for halothane, isoflurane and pentobarbitone and inactivation significantly decreased for isoflurane sevoflurane 
and pentobarbitone (Table 2). Therefore, in addition to a reduction in whole-cell calcium channel current, it is clear that these drugs have 
differential effects on calcium channel gating kinetics.
The effect of anaesthetics on the current-voltage relationship of IBa
To determine the effect of drugs on the current-voltage relationship, I-V plots were constructed for mean peak and end-pulse current 
recorded from several cells and normalized to control values of IBa(max). Thus, for halothane, two families of I-V curves were produced, 
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Figure 3: A) Dose-dependent reduction of IBa by halothane. Halothane was applied successively at 1, 2 and 4% to a single LYC neuron with 
washes in between. Peak current was monitored and standard I-V pulse protocols were run during the plateau of maximal drug response. 
Superimposed currents represent IBa(max) measured as -8 mV in this instance for both the control and test conditions. B) Time course of 
peak and end-pulse IBa currents recorded from an LYC during a typical experiment in response to unitary 70 ms depolarising pulses to 
-0mV from a holding potential of -70 mV. Halothane was introduced at the concentration and duration indicated by horizontal bars.
Mean activation slope (nA/mV) ± S.E Mean inactivation slope (nA/mV) ± S.E
Control Drug Control Drug
Halothane −12.87 ± 2.44 *−6.45 ± 1.34 0.525 ± 0.070 0.688 ± 0.085
Isoflurane −13.31 ± 1.38 *−9.19 ± 1.34 0.529 ± 0.079 *0.848 ± 0.065
Sevoflurane −6.93 ± 0.99 −6.00 ± 1.35 0.288 ± 0.038 *0.464 ± 0.085
Pentobarbitone −10.13 ± 1.58 *−6.95 ± 1.19 0.515 ± 0.073 *0.722 ± 0.148
Table 2: Mean maximum slope of IBa traces, measured before (activation) and after (inactivation) the slope turning point at peak  
amplitude. Volatile anaesthetics were applied at 4% and pentobarbitone at 800 µM. Traces were smoothed with a Gaussian filter at 300 Hz 
cut-off before taking measurements. Significant statistical differences of slopes compared to control values (marked with an asterisk) were 
evaluated using Student’s two tailed, paired t-test at the 5% level, n = 5 for each data set. Differences in control values reflect variations in 
average animal size, and hence LYC size, of the batch of samples.
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each for control conditions and for halothane at 1, 2 and 4% (Figure 4A). These show that increasing halothane concentration reduces 
IBa in a dose-dependent manner across the entire voltage range, with end-pulse current being slightly more sensitive to the anaesthetic. 
The I-V curve shape is well preserved across the voltage range except at the most positive test potentials when anaesthetic concentration 
was high. Here, net outward current increases, especially for end-pulse current where Erev has fallen from 40 to 25 mV. This effect was 
less apparent for other anaesthetics tested but could indicate either that calcium channel kinetics are altered in direct response to the 
anaesthetic or that an unspecified repolarizing current, such as a K+ channel current, was being activated at the higher drug concentration.
Similar families of I-V curves were produced for isoflurane, sevoflurane and pentobarbitone, which differed principally in their dose-
response profile. These are summarized as dose-response plots of IBa(max) in figure 4B for volatile anaesthetics and 4C for pentobarbitone 
(R2 > 0.99 in all instances). Therefore, IBa is reduced in direct proportion to the concentration of anaesthetic for both the volatile and 
non-volatile drugs within the concentration range of drugs used. The proportional decrease in IBa(max) for a given concentration of drug is 
greater for end-pulse currents which have steeper dose-response slopes. For the volatile anaesthetics, halothane produces the greatest 
depression of IBa, followed by isoflurane, and then sevoflurane. The slope coefficients for peak currents show wider variation compared to 
those of end-pulse currents, where the regression slopes are divergent. Hence, the relative ability of the volatile anaesthetics to depress 
IBa are different when comparing peak and end-pulse IBa(max) regressions of dose-response. Sensitivity of IBa to pentobarbitone in the range 
0.2 - 0.8 mM is about twice that for volatile agents, which had an equivalent dose range of approximately 0.4 - 1.6 mM. Pentobarbitone, a 
compound physically and chemically distinct from volatile anaesthetics, also has a linear dose-response profile at these concentrations.
Figure 4: A) The effect of halothane concentration on I-V curves of mean peak and end-pulse IBa normalised to control IBa(max) and showing 
± S.E.M. as vertical bars. For each trial halothane was introduced successively at 1% (), 2% (    )and 4% (≥), interspersed by washes 
of 2 - 3 minutes which reversed the effects completely (control ). IBa(max) was monitored throughout and pulse I-V protocols performed 
during the plateau of maximal response to the drug. B) Normalised means of IBa(max) for peak and end-pulse currents are plotted against 
percentage volatile anaesthetic concentration for halothane (), isoflurane (   ) and sevoflurane (). Vertical bars indicate s.e.m. where n 
= 6 for halothane and n = 7 for isoflurane and sevoflurane. C) Normalised means of IBa(max) for peak () and end-pulse () currents plotted 
against pentobarbitone concentration. Linear regressions are fitted though each dose-response plot in 4B and 4C using the least squares 
method. All have an R2 value greater than 0.99.
Citation: Terence J Morris ., et al. “A Comparative Study of Anaesthetic Agents on High Voltage Activated Calcium Channel Currents in 
Identified Molluscan Neurons”. EC Neurology 13.3 (2021): 38-52.
A Comparative Study of Anaesthetic Agents on High Voltage Activated Calcium Channel Currents in Identified Molluscan Neurons
46
 The anaesthetics investigated produced a reversible dose-dependent depression of IBa in LYCs of Lymnaea stagnalis and, in all cases, 
current at peak amplitude was less sensitive than that recorded at the end of the depolarizing pulse. Most of the drugs tested produced a 
significant decrease in activation rate and an increased inactivation rate. Plots of IBa(max) against anaesthetic concentration correlate highly 
to linear functions so that the potency of the drug to depress IBa is proportional to the straight-line slope of the regression.
Discussion
The aim of these experiments was to compare the effects of a number of general anaesthetic agents on whole cell calcium channel cur-
rents recorded from identified light yellow cells, located in the central ganglia of Lymnaea stagnalis. The results show that these agents 
alter calcium channel function, represented as the dose-dependent depression of a calcium channel current, often associated with a 
decreased rate of activation and accelerated inactivation. Moreover, use of a single model system provides a reliable assay for comparing 
the relative effects of drugs. In solutions containing Ba2+ as the charge carrying ion, large inward currents were observed when cells were 
depolarized. That these currents are carried though Ca2+ channels is supported by the following: (1) The experiments were performed 
under conditions designed to eliminate as far as possible currents carried by ions other than Ca2+ or Ba2+ (See methods). (2) Any increase 
or decrease in [Ba2+]out produced a corresponding change in IBa(max), whilst excluding Ba2+ ions from the recording solution reversibly oblit-
erated IBa. (3) The current was blocked by the calcium channel blocker Cd2+ though not by nifedipine or verapamil. IBa appears to have two 
HVA components, Isus and Itrans, which were indistinguishable by their steady state inactivation kinetics and the pharmacological probes 
used in this study. Molluscan neuron calcium channel identification cannot always be made on the basis of the L-, N-, and T-type currents 
seen in vertebrate neurons. The resistance of IBa to the dihydropyridine nifedipine makes it unlikely that any L-type channel currents were 
present in these cells, although they were previously demonstrated in cultured pedal I cluster neurons of Lymnaea [4]. In addition, the 
time constant for IBa inactivation (τ ≈ 50 - 90 ms) is relatively fast for L-types, more within the range of N-type calcium channels, to which 
IBa is otherwise dissimilar. Compared to N-types IBa possesses an activation range too negative, and a holding potential too positive for 
their complete steady state inactivation. Pharmacological characterization of IBa using more specific calcium channel blockers, such as the 
ω-conotoxins and ω-agatoxins, would therefore be of interest.
Halothane produced the steepest dose-response slope, followed by isoflurane and then sevoflurane. The order of potency of these 
anaesthetics to depress IBa reflects their clinical order of potency, in terms of MAC value (the minimum alveolar concentration required to 
induce anaesthesia in 50% of the population) [37], illustrated in figure 5. This is a remarkable finding, perhaps signifying the importance 
of HVA Ca2+ channel responses in anaesthetic action, as well as endorsing the suitability of Lymnaea CNS as a model system in studies of 
this type. However, there are complex tissue and channel specific variations of response to general anaesthetics, which appear to exclude 
a simple unified mechanism of action. In this respect these results contrast sharply with those of McDowell., et al. [5] for LVA T-type cur-
rents in dorsal root ganglion neurons and two neuroendocrine cells, with isoflurane and enflurane being more potent than halothane. 
Pentobarbitone also produces dose-dependent depression of IBa recorded from LYCs, even though barbiturates are physically and 
chemically distinct from volatile agents. Similar depression of the HVA human recombinant α1a P/Q type channels by pentobarbital has 
been demonstrated elsewhere [38] and involves slow open channel block. However, both sets of findings would appear to cast doubt on 
some physiochemical theories of anaesthetic action, for example, the correlation between gas-lipid solubility and anaesthetic potency 
(For a discussion of physiochemical theories see [39]), at least in terms of effects on voltage gated calcium channels. However, the discov-
ery of soliton pulses associated with action potentials [40-42] may yet provide an alternative explanation of anaesthetic actions [43] and 
may yet unify the modern lipid and membrane protein hypotheses of anaesthesia. 
The fact that the HVA currents we have reported here are insensitive to both nifedipine and verapamil strongly suggest that they are 
LCav2 type channels originally described in Lymnaea VD4 neurons [44], but further work will be required to demonstrate this with cer-
tainty. Unlike mammalian Cav2.1 and Cav2.2 channels, the Lymnaea channels are inhibited slowly by G-protein dependent activation of 
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Figure 5: The relative potency of Isoflurane and Sevoflurane in proportion to halothane: to suppress IBa (as the gradient of dose-response 
regression slopes) (at right) and when expressed as MAC (at left). Values are normalised to halothane, which is taken as unity.
cAMP, whereas activity-dependent G-protein regulation has evolved in vertebrates, where the G-proteins contain βγ subunits which are 
missing in Lymnaea.
The suppression of voltage-dependent calcium currents is likely to have multiple effects on neuronal function. For example, P/Q type 
currents are thought to be carried via Cav2.1 channels and are directly involved with synaptic vesicle exocytosis, which is inhibited by 
isoflurane in rat dopaminergic midbrain neurons, but non-dopaminergic neurons were insensitive to isoflurane [45]. However, barbi-
turates are also known to inhibit noradrenaline and dopamine release with the P/Q voltage sensitive calcium channels [46]. Moreover, 
many secondary messenger pathways, including Ca2+ channel activity itself, are modulated by [Ca2+]i. The ability of ATP to arrest HVA Ca2+ 
channel current rundown, observed here and elsewhere, supports the idea of phosphorylation being central to their maintaining their 
activity [47]. Elements of protein kinase mediated regulatory pathways are feasible targets for general anaesthetics given the heteroge-
neous effects these agents have on cells. Firestone and Firestone [48] found that clinically relevant concentrations of various structurally 
heterogeneous general anaesthetics reduced PKC binding to an activating ligand in a concentration-dependent manner.
Voltage-dependent Ca2+ influx supports Na+ mediated depolarisations, so one would expect cell excitability to be reduced by the Ca2+ 
blocking effects of the agents. It has been shown, using the same model system, that a calcium-dependent pseudoplateau of action poten-
tials is abbreviated in the presence of halothane [49-51]. Thus, a briefer and impoverished Ca2+ influx is represented at synapses and since 
calcium influx is a crucial event in neurotransmitter release [52], synaptic transmission is likely to be inhibited. Investigations on in vivo 
and reconstructed synapses between Lymnaea neurons have revealed that halothane affects both inhibitory and excitatory responses of 
pedal A cluster neurons challenged by FMRFamide or electrical stimulation of the pre-synaptic cell [53,54]. However, halothane [2] and 
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pentobarbital [25] have also been found to mobilize calcium from internal stores in cultured Lymnaea neurons: halothane can do this in 
the absence of external calcium, but pentobarbital cannot, presumably because it modifies the lipid-raft-protein interactions in the cell 
membrane, [55] thereby depressing calcium entry.
Depression by anaesthetics of IBa together with observed changes in activation and inactivation could be related macroscopically to 
channel opening probabilities or to alterations in single channel kinetics, and this cannot be discerned from whole cell recordings. In 
ω-conotoxin sensitive and DHP resistant calcium channels expressed from human cortical RNA, both the rate of inactivation of open 
channels, as well as the proportion of channels inactivated, were increased by barbiturates [56]. The changes in both activation and in-
activation rates of IBa argues against a simple blocking mechanism or a decrease in the number of channels available for activation. This 
study confirms that anaesthetic agents can accelerate calcium current decay, shown previously, for example in pedal I cluster neurons 
of Lymnaea for halothane [4]; in Helix for barbiturates [57]; and for halothane in various vertebrate cells, including clonal pituitary cells 
[58], rat sensory neurons [59]; hippocampal CA1 neurons [60] and bovine adrenal chromaffin cells [61]. Depression of calcium current by 
antagonists belonging to the dihydropyridine (DHP) class of drugs is similarly accompanied by accelerated inactivation [62-64] though 
not invariably [65].
Contrasting with the findings of this study and those of Yar and Winlow [4], in which volatile anaesthetics produce little or no dis-
placement of the I-V curve along the voltage axis, DHPs tend to shift calcium channel inactivation to more negative potentials. In addition, 
divalent cation concentrations in the perfusate are known to reduce the potency of these drugs [64]. Conversely, volatile anaesthetic in-
duced depression of Ca2+ influx through L-type and DHP insensitive voltage operated channels is not relieved by increasing [Ca2+]out [65], 
indicating that anaesthetic action is independent of changes in surface potential.
Conclusion
Our results show that a variety of general anaesthetics, including the non-volatile pentobarbitone, produce dose-dependent depres-
sion of whole cell HVA Ca2+ channel current, IBa. The depression of IBa is in direct proportion to drug concentration and differences in dose-
response between agents is principally one of magnitude. The efficacy of halothane, isoflurane and sevoflurane to depress IBa reflects their 
rank order of clinical potency when expressed as MAC values. Thus, the effect of general anaesthetics on neuronal HVA calcium channels 
may be fundamental to clinical response. 
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